Transamerica Life Insurance Fit Review for Obesity

Research Snapshot

Why Transamerica Qualified for This Study

Questions This Section Answers

• Why did Transamerica qualify as a finalist for life insurance with obesity?
• Does Transamerica publish height-and-weight build charts that a high-BMI buyer can review before applying?

Transamerica qualified because it publishes carrier-specific height-and-weight build charts rather than leaving weight treatment unspecified, and because multiple platforms identified it as a carrier that will manually review borderline build cases. Its underwriting field guide publishes height-and-weight limits by age and risk class; for ages 18 through 70, the Trendsetter chart lists maximum weights at 5'8" of 178 pounds for Preferred Plus, 195 for Preferred, 204 for Standard Plus, and 220 for Standard, and the guide states this build chart applies to Trendsetter LB bands 3 and 4 ^[1].

That published chart is the clearest company-owned evidence in this study that Transamerica evaluates build explicitly rather than treating BMI as an automatic decline trigger. Independent reviewers go further, describing Transamerica as one of the most lenient major carriers on BMI and noting that where weight is the only impairment, it frequently achieves Standard rates where competitors assign table ratings ^[2].

The qualification is not unanimous. Google's platform rated Transamerica's charts relatively conservative for higher BMIs, placing standard classes around BMI 33–35 and Table 2 through Table 8 ratings for BMIs of 35–44 ^[4]. That conflict is central to this review and is not resolved by the supplied evidence.

Transamerica also qualified on product breadth. It markets term life through the Trendsetter series plus permanent products including universal and indexed universal life ^[5], and it offers accelerated and, for certain applicants, nonmedical underwriting pathways ^[6].

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Obesity

Questions This Section Answers

• Which Transamerica plan should a high-BMI buyer ask about first, Trendsetter Super or Trendsetter LB?
• Does Transamerica Trendsetter LB include living benefits that matter for an applicant with obesity-related conditions?

Trendsetter Super and Trendsetter LB term life insurance are the most relevant Transamerica products for this use case. Trendsetter Super is conventional term life insurance, while Trendsetter LB is term insurance with critical, chronic, and terminal illness accelerated-death-benefit features ^[7]. For a consumer primarily seeking affordable income-replacement or debt-protection coverage, term is the most directly relevant chassis.

Coverage limits differ by product. Independent reviews state Trendsetter Super covers $25,000 to $10 million and Trendsetter LB covers $25,000 to $2 million ^[9]. Transamerica's own term page states simplified underwriting with no medical exam up to $2 million for qualified applicants ^[11]. A consumer brochure states nonmedical underwriting may be available for Trendsetter LB at ages 18 through 45 for policies up to $2 million, ages 46 through 55 up to $1 million, and ages 56 through 60 up to $249,999 ^[13].

Living benefits carry tradeoffs. Transamerica states that amounts paid under Trendsetter LB living benefits may be discounted, administrative fees may apply, benefits reduce the remaining death benefit and policy value, and riders have limitations, exclusions, and jurisdictional availability restrictions ^[8]. Certain medical conditions can affect eligibility for living benefit coverage, and Transamerica reserves the right to decline riders ^[14].

Product naming is not fully stable across sources. Deepseek reported that whether the Trendsetter series remains marketed under that exact name in 2026 is unclear from the pages it reviewed ^[15], and Kimi flagged that specific 2026 product names and current availability were unverified in independent sources. Buyers should confirm the current product name and form with the carrier or broker.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Transamerica for high-BMI life insurance applicants?
• Does Transamerica use height and weight in life insurance underwriting?

Platforms agreed on four points. First, Transamerica uses height and weight as underwriting inputs alongside blood pressure, cholesterol, diabetes, and related factors. Transamerica's own materials state that actual premiums vary based on health history, company-determined underwriting status, age, height, weight, sex, and coverage preferences ^[16], and its consumer pages state that height and weight are collected during the application ^[18].

Second, Transamerica offers multiple underwriting pathways. Trendsetter Super and Trendsetter LB may be available through traditional underwriting, while a point-of-sale or accelerated pathway can use electronic application, MIB, motor-vehicle, and prescription records without an exam or laboratory testing for eligible cases ^[19]. Transamerica states all Trendsetter Term life products are eligible for Accelerate, and certain previously underwritten customers may obtain a Trendsetter policy without a new medical exam ^[20].

Third, no platform found a published obesity-specific acceptance guarantee. OpenAI stated Transamerica does not publish a consumer-facing obesity-specific acceptance policy or guaranteed rates. Deepseek stated Transamerica's public life insurance pages do not publish BMI ranges, build charts, table-rating bands, or specific height/weight acceptance limits. Perplexity stated the reviewed materials do not show an obesity-specific program or guaranteed preferred treatment for high-BMI applicants.

Fourth, pricing is quote-dependent. Transamerica's quote disclaimers describe online figures as estimates subject to underwriting, with actual premiums dependent in part on health history, height, weight, age, sex, underwriting status, and coverage preferences ^[16].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Do AI platforms disagree about Transamerica's BMI limits for life insurance approval?
• Is Transamerica's underwriting for obesity predictable enough to rely on before applying?

The platforms disagreed sharply on BMI thresholds, and this is the single most important uncertainty for a buyer. Kimi reported that Transamerica accepts Standard rates up to BMI 34 automatically and up to BMI 37 with underwriter discretion, with table ratings for BMI 37–43 and decline above BMI 43 ^[21]. Anthropic reported a similar structure: Standard up to BMI 34 automatic, up to 37 with discretion ^[22]. Grok reported blended BMI charts allowing Standard rates up to BMI ~35 and table ratings up to ~46 before decline for ages 16–59 ^[24]. Google reported the opposite direction, describing Transamerica as relatively conservative with standard classes around BMI 33–35 and Table 2–8 ratings for BMIs of 35–44 ^[26].

These are not reconcilable from the supplied evidence. The spread between "decline above 43" and "table ratings up to 46" and "conservative above 35" means a buyer cannot predict an outcome from public sources alone.

Platforms also disagreed on predictability as a feature. Kimi framed manual underwriting discretion as the core advantage, noting that a BMI 36 applicant declined or table-rated elsewhere may receive Standard approval with a strong broker cover letter ^[21]. Anthropic framed the same discretion as the core risk, noting that identical cases can receive different outcomes depending on which underwriter reviews the file ^[27]. Both descriptions can be true simultaneously, and the supplied evidence does not establish which effect dominates.

Two further uncertainties are unresolved. Deepseek, which ran without search enabled, reported that Transamerica does not publicly disclose BMI thresholds or obesity-specific rate classes and that no company-specific obesity outcome can be verified from public sources. And Google flagged that exact maximum BMI thresholds for immediate decline can vary by state, age, and product line, and are not publicly disclosed outside restricted broker field guides.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• How does Transamerica underwrite controlled diabetes or sleep apnea alongside a high BMI?
• What coverage amounts can a high-BMI applicant request from Transamerica without a medical exam?

Transamerica's most cited use-case advantage is discretionary review of borderline build cases. Independent reviewers state that Transamerica does more manual underwriting than most carriers, giving underwriters discretion, and that for applicants whose only impairment is weight, Transamerica is frequently the winning carrier ^[28]. One review states that Transamerica's build chart means BMI ranges that trigger Table B–C elsewhere come back Standard ^[30].

Comorbidity handling is described favorably but only by independent review sites, not by company materials. For controlled type 2 diabetes, reviewers state that applicants diagnosed after 50 with A1C under 7.5, on oral medication, and no complications frequently receive Standard rates, while younger onset or insulin use typically results in table rating rather than decline ^[31]. For sleep apnea, documented CPAP compliance with a follow-up sleep study showing controlled apnea can yield Standard or better ^[34]. For controlled hypertension and cholesterol, reviewers state these are usually not major rate drivers if controlled long-term ^[36]. Transamerica's own materials do not provide public condition-by-condition rules for diabetes, blood pressure, cholesterol, mobility, or sleep apnea ^[38].

Underwriting pathways matter for a high-BMI applicant who wants to avoid an exam. Transamerica's point-of-sale program excludes Hawaii, New York, Guam, the U.S. Virgin Islands, and Puerto Rico, and Trendsetter LB is separately stated as unavailable in New York in its quote disclaimer ^[38]. Independent reviews state Trendsetter Super is unavailable in New York ^[41].

Table ratings carry defined cost. Google reported that Transamerica's substandard rates are 25% per table based on Standard Nonsmoker or Standard Smoker rates, ranging from Table A to Table H ^[42]. That is a company-owned figure and the most concrete pricing mechanic in this study.

Weight-loss timing is a documented limitation. Google reported that Transamerica evaluates recent weight loss on a lookback basis, typically factoring in only a portion of weight lost within the last 12 to 24 months to ensure weight stability ^[43]. A buyer who has recently lost weight should not assume the lower weight is credited immediately.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Transamerica term life cost per month for a high-BMI applicant, and are there table-rating surcharges?
• What happens to Transamerica Trendsetter premiums after the initial level-term period ends?

No reliable public price can be stated for a high-BMI applicant. OpenAI reported that public materials do not provide a reliable premium range for a consumer with obesity without age, sex, face amount, term length, tobacco status, state, and detailed health information, and rated pricing confidence low. Deepseek and Perplexity also rated pricing confidence low, and Grok rated it moderate with the note that specific premiums depend on age, health, coverage amount, and underwriting outcome.

The available price anchors are for standard profiles, not obesity cases. Independent reviews state Transamerica's average annual premium is $273, about 26% below a national average of $382, and that a 40-year-old nonsmoker pays $37 per month (female) or $46 per month (male) for $500,000 of 20-year term, roughly 21% below national average ^[46]. These figures do not describe a table-rated high-BMI applicant and should not be applied to one.

Table ratings are the main cost lever. Google reported each letter table (Table A through H) adds a 25% surcharge to the base standard premium, up to a maximum 200% surcharge ^[49]. Kimi reported that table-rated policies for BMI 37–43 carry higher premiums than Standard, with the degree varying by case.

Post-level-term costs are a documented long-term risk. OpenAI reported that Trendsetter LB premiums increase annually after the initial level-premium period: after year 10 for a 10-year policy, year 15 for a 15-year policy, year 20 for a 20-year policy, year 25 for a 25-year policy, and year 30 for a 30-year policy ^[50]. Anthropic described the same structure for Trendsetter Super's yearly renewable term pricing, with increases beginning year 11, 16, 21, 26, or 31 depending on term length.

Rider and administrative costs apply to living benefits. Transamerica states that administrative fees may apply when accelerated benefits are requested, and that certain riders may be available at additional cost ^[51]. Anthropic reported that living benefit riders are included on Trendsetter LB at no additional cost but require additional premium on Trendsetter Super. These two descriptions are not fully consistent and should be verified for the specific policy form.

Contract terms are only partly public. OpenAI reported that the reviewed materials do not provide a universal cancellation-refund schedule or guaranteed-conversion terms for every state and product variation. Anthropic reported a two-year contestability period and a suicide limit applying to the first two policy years, and conversion availability before age 70 or 75 depending on rate class ^[52]. Google reported policies are guaranteed renewable up to age 105 with premiums increasing annually after the initial guaranteed level term period.

Best Suited For

Questions This Section Answers

• Is Transamerica a good choice for a buyer with BMI 35–37 and otherwise clean lab results?
• Who gets the most value from Transamerica's manual underwriting discretion?

Transamerica is best suited to applicants whose weight is the primary impairment and whose related health markers are controlled. Kimi's assessment places the sweet spot at BMI 35–37 with otherwise favorable markers such as controlled blood pressure, normal A1C, and stable lipids, and at BMI 36–43 for applicants already table-rated or declined by carriers with stricter automated build charts ^[53]. Anthropic's assessment is similar: BMI 28–37 with controlled comorbidities, and cases combining high BMI with anxiety, depression, or other conditions requiring flexibility ^[54].

A second fit group is applicants who want no-exam coverage. Transamerica states simplified underwriting can include no medical exam up to $2 million for qualified applicants ^[56], and a consumer brochure describes nonmedical underwriting availability by age band for Trendsetter LB ^[58].

A third fit group is buyers who want conversion optionality. Independent sources state term conversion allows automatic qualification for the same rate class with no additional underwriting, available before age 70 or 75 depending on rate class ^[59]. For a high-BMI buyer who expects future health changes, that feature has practical value.

A fourth group is applicants working with an independent broker who can submit a cover letter documenting stable weight and clean labs. Kimi reported that broker-submitted cover letters can positively influence outcomes, and that this advantage is most valuable when paired with an informed broker.

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Transamerica for life insurance with obesity?
• Is Transamerica a poor fit for a buyer who needs guaranteed acceptance or predictable underwriting?

Buyers who need guaranteed acceptance or coverage without meaningful medical underwriting should look elsewhere. OpenAI listed applicants needing guaranteed acceptance or coverage without meaningful medical underwriting among those Transamerica is probably not best for. Deepseek listed buyers seeking guaranteed issue or no-exam coverage where BMI is not used to decline or rate the policy. Kimi stated Transamerica is not a leader in no-exam or guaranteed issue products for those wanting to avoid medical evaluation entirely.

Buyers who need a predictable outcome before applying are also a poor fit. Anthropic listed BMI 35+ without strong mitigating factors or a favorable broker cover letter among those Transamerica is probably not best for, and flagged manual underwriting unpredictability as a limitation. Kimi listed applicants wanting highly predictable, consistent underwriting outcomes and noted decline is likely above BMI 43.

Buyers with multiple or poorly controlled comorbidities alongside high BMI are a weaker fit. OpenAI listed applicants with substantially elevated weight plus poorly controlled diabetes, hypertension, sleep apnea, cardiovascular disease, mobility limitations, or other material impairments. Google listed applicants with severe obesity (BMI over 35 to 40) who need highly lenient build charts, and applicants with obesity combined with poorly controlled comorbidities.

Buyers who prioritize service experience should weigh complaint data. Independent reviews report a NAIC complaint index of 3.86–3.87, nearly four times the industry average of 1.0, and a J.D. Power score of 604 ranking 18th of 21 carriers, with most complaints involving policy service and billing rather than claim denials ^[61]. U.S. News reported a 2025 complaint rate over four times higher than expected ^[65]. These are independent review-site figures and should be checked against current NAIC data.

Buyers who want a purely digital purchase path are also a poor fit. Independent reviews state online quotes are available only for Trendsetter Super and most other products require agent contact ^[66].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Transamerica for a buyer with BMI above 37?
• When should a high-BMI buyer choose Prudential, Banner Life, or a guaranteed-issue policy instead of Transamerica?

Another carrier may be better when BMI is high enough that Transamerica's discretion is unlikely to help. Anthropic reported that Prudential and Mutual of Omaha consider applicants with BMI up to 45, and that Prudential allows Standard rates up to BMI 36 with SBLI's build chart similarly generous ^[67]. Kimi reported that Prudential is noted as excellent for diabetes plus obesity combinations and that Banner Life offers competitive Preferred Plus rates up to higher BMI. Google listed Prudential, Banner Life, and Protective Life as more lenient high-BMI carriers.

Another carrier may be better when the buyer wants the lowest absolute price at moderate BMI with clean health. Anthropic reported that Banner Life often prices better for BMI 30–35 with excellent health markers. Kimi reported that price-sensitive buyers may find better rates at Prudential or Banner Life for BMI 30–37.

A guaranteed-issue or simplified-issue product may be better when the buyer cannot or will not complete medical underwriting. OpenAI listed guaranteed-issue, simplified-issue, or final-expense coverage as an alternative when the buyer accepts lower limits or higher premiums. Kimi reported that guaranteed acceptance alternatives from Mutual of Omaha, Gerber Life, and AIG cost more per dollar of coverage and cap at $25,000–$50,000, and that guaranteed issue policies have graded death benefits in the first two to three years ^[69].

A permanent product from another carrier may be better when the buyer needs cash-value guarantees. Anthropic reported that Transamerica offers indexed universal life but lacks guaranteed universal life, and listed Penn Mutual, American National, Corebridge, and Pacific Life as stronger alternatives for guaranteed permanent coverage.

A different carrier may be better when the buyer resides in New York. Transamerica's point-of-sale program excludes New York, and Trendsetter Super is unavailable there ^[70].

Questions to Verify Before Buying

Questions This Section Answers

• What should a high-BMI buyer confirm with Transamerica before signing a life insurance contract?
• How can a buyer test whether Transamerica's discretionary underwriting will work in their favor?

The platforms converged on a similar verification list. Before applying, a buyer should confirm the exact height-and-weight build table for the specific state and product, and whether the application will qualify for no-medical-exam or accelerated underwriting or require a full exam ^[72]. OpenAI's list adds confirming the realistically available risk class before and after full underwriting for the applicant's exact height, weight, age, state, and requested face amount.

Comorbidity documentation should be assembled in advance. Buyers should confirm how current or prior diabetes, A1C, blood pressure, cholesterol, sleep apnea treatment and compliance, mobility limitations, bariatric surgery, weight trend, and related medications will affect eligibility and rating, and whether an exam, blood or urine testing, attending-physician statement, or additional medical records will be required despite an initial accelerated or nonmedical indication.

Cost and contract terms should be confirmed in writing. Buyers should request the guaranteed premium schedule after the initial term including exact annual increases, and confirm rider charges, administrative fees, discounts, exclusions, and reductions to the death benefit that apply to Trendsetter LB living benefits ^[74]. Conversion rights should be confirmed, including the age or date limit and whether converted products are subject to new underwriting.

Weight-loss timing deserves a specific question. Google reported that recent weight loss within 12 to 24 months is evaluated on a lookback basis, with only a portion credited ^[75]. A buyer who has lost weight recently should ask how much will be added back for build classification.

Finally, buyers should compare classes across carriers before committing. Anthropic recommended comparing Transamerica's underwriting class decision against two or three other carriers including Banner Life, Prudential, and SBLI, and asking whether weight loss or health improvement allows reconsideration after 6 to 12 months.

Final AI Consensus Verdict

Transamerica is a mixed fit for life insurance with obesity, and the mixed rating is the honest answer rather than a hedge. Five of seven platforms named it during ranking discovery, and its genuine strength is discretionary manual underwriting that independent reviewers say can produce Standard rates for borderline BMI cases where automated build charts at other carriers table-rate or decline. Its genuine weakness is that the same discretion makes outcomes unpredictable, and the platforms could not agree on whether Transamerica's build charts are generous or conservative for high BMI.

The practical conclusion for a buyer is narrow. Transamerica is worth including in a broker-run comparison, particularly for term coverage when weight is the primary impairment, related conditions are controlled, and the applicant is willing to accept that the outcome depends on which underwriter reviews the file. It should not be treated as a confirmed obesity-friendly carrier, because no platform found a published obesity-specific acceptance policy, BMI thresholds conflict across sources, and pricing for a high-BMI applicant cannot be stated from public information.

Buyers comparing carriers for this use case can review the broader Life Insurance for Obesity consensus index, and general background on how carriers evaluate health conditions is available in the life insurance category directory.

How This Review Was Produced

This review was produced from seven platform responses collected for the research date 2026-09-22. Each platform independently evaluated Transamerica's fit for a U.S. consumer with a high body mass index seeking life insurance, and each supplied its own citations, fit rating, strengths, limitations, pricing notes, and verification questions. Five of the seven platforms named Transamerica during ranking discovery; all seven supplied a fit assessment.

Platform fit ratings were not uniform. Kimi rated Transamerica a strong fit, Anthropic and Grok rated it a good fit, and OpenAI, Deepseek, Google, and Perplexity rated it a mixed fit. This review reports those ratings as platform-reported opinions rather than verified conclusions, and it does not treat platform agreement as evidence of product quality.

Citations in this review are platform-reported evidence. Company-owned sources include Transamerica underwriting guides, product brochures, quote disclaimers, and consumer pages. Independent sources include insurance review sites, broker directories, industry forums, and government publications from NAIC and the CFPB. Where a claim rests only on a review site or forum rather than a company document or government source, this review labels it as reported by that source rather than established fact.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date: Deepseek reported a research date of 2026-02-14 while the run research date is 2026-09-22, and platform-reported dates are provenance metadata that do not independently prove freshness. Deepseek also ran without search enabled, so its claims require explicit verification before being described as current facts.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. No platform reported personal testing, customer experience, or independent verification of Transamerica's underwriting outcomes.

Material conflicts were left unresolved rather than guessed. BMI thresholds conflict across sources, ranging from a reported decline above BMI 43 to table ratings up to roughly BMI 46 to a characterization of Transamerica as conservative above BMI 35. Product naming is not stable across sources, and whether the Trendsetter series remains marketed under that exact name in 2026 was flagged as unclear. Living benefit rider cost is described as included at no additional cost by one source and as requiring additional premium on Trendsetter Super by another.

Pricing evidence is weak for this use case. No platform produced a verifiable premium for a high-BMI applicant, and the available price anchors describe standard health profiles rather than table-rated cases. Complaint statistics come from independent review sites and were not confirmed against current NAIC documentation within the supplied evidence.